In experimental stroke models, N-Acetylcysteine, a mucolytic drug, and ADAMTS13, a vWF cleaving enzyme, have shown to effectively dissolve tPA resistant thrombi and reduce cerebral infarct size (90, 91). The gene discussed is ADAMTS13; the disease is Stroke.